A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We present a novel approach for two-photon microscopy of the tumor delivery of fluorescent-labeled iron oxide nanoparticles to glioblastoma in a mouse model.

Abstract

The delivery of intravenously administered cancer therapeutics to brain tumors is limited by the blood-brain barrier. A method to directly image the accumulation and distribution of macromolecules in brain tumors in vivo would greatly enhance our ability to understand and optimize drug delivery in preclinical models. This protocol describes a method for real-time in vivo tracking of intravenously administered fluorescent-labeled nanoparticles with two-photon intravital microscopy (2P-IVM) in a mouse model of glioblastoma (GBM).

The protocol contains a multi-step description of the procedure, including anesthesia and analgesia of experimental animals, creating a cranial window, GBM cell implantation, placing a head bar, conducting 2P-IVM studies, and post-surgical care for long-term follow-up studies. We show representative 2P-IVM imaging sessions and image analysis, examine the advantages and disadvantages of this technology, and discuss potential applications.

This method can be easily modified and adapted for different research questions in the field of in vivo preclinical brain imaging.

Introduction

Two-photon intravital microscopy (2P-IVM) is a fluorescence imaging technique that allows the visualization of living tissue1.

First developed in the 1990s, 2P-IVM has been used for in vivo analysis of the retina2, kidney3, small intestine4, cochlea5, heart6, trachea7, and the brain in various preclinical models8,9. In the field of neuroscience, 2P-IVM has gained importance as a technique for real-time imaging of the healthy brain in awake animals10, as well as studying diseases of the nervous system such as Alzheimer's11, Parkinson's12 and glioblastoma (GBM)13,14,15,16.

2P-IVM offers an elegant solution for studying the tumor microenvironment during the development of GBM. While some previous studies focused on in vitro17 and ex vivo models18, others implemented orthotopic19 and xenotropic20Β in vivo models for examining GBM. Madden et al. performed native imaging of CNS-1 rat glioma cell line in a mouse model13. Using an orthotopic GL261-DsRed murine model, Ricard et al. performed an intravenous administration of a fluorophore to enhance the blood vessels in the tumor region in 2P-IVM14.

Here, we apply 2P-IVM for tracking the tumor delivery of fluorescent-labeled iron oxide nanoparticles (NP) in an orthotopic mouse model of GBM. Using a cranial window, this method allows us to study the real-time spatiotemporal distribution of NPs in the brain in detail.

Protocol

The animal procedure described in this protocol is in accordance with the requirements of the Administrative Panel on Laboratory Animal Care (APLAC).

1. Cell culture

  1. Preparation of hood
    1. Wash hands, wear gloves and a lab coat. Turn on the biological safety cabinet and set the sash level to an appropriate opening height. Let the hood purge for 3-5 min. Spray the hood area with 70% ethanol and wipe it down with tissue paper.
    2. Spray all reagents with 70% ethanol and wipe down with tissue paper. Move the reagents into the hood. Do not put any items on the grill. If a spill occurs in the hood, cover it with wipes, spray it with 70% ethanol, and wipe again.
    3. After the experiment, carefully close the lids of each item, wipe down all materials, remove any items from the hood, and transfer them to their original location. Spray 70% ethanol in the hood and wipe it down. Shut the sash and turn off the biological safety cabinet.
  2. Preparation of a growth medium
    1. Add 50 mL of 100% fetal bovine serum (FBS) to 500 mL Dulbecco’s Modified Eagle Medium (DMEM). Add 5 mL of the antibiotic-antimycotic solution (100x).
    2. Pass all the reagents through a sterile 500 mL filtering bottle (0.22 Β΅m filter).Β 
  3. Thawing of cryopreserved cells
    1. In a laminar flow hood, add 20 mL of the growth medium to a T75 flask. Label the flask with the name of cells, date, and passage number on the flask. In this study, adherent C6 glioma cells were used.
    2. Thaw cells quickly in a 37 Β°C water bath. Do not vortex the cells. Thaw and immediately use the cells.
    3. Transfer the thawed cells to the T75 flask using a 1 mL pipette tip. Be careful not to introduce any bubbles during the transfer process, and avoid any medium residue in the neck of the flask. This could increase the risk of possible contamination.
  4. Changing the medium
    1. Change the medium on the day following thawing to remove any residual trypsin or dimethyl sulfoxide (DMSO) (step 1.6). Afterward, change the medium at least two times per week or more, depending on cell confluency level. The medium must be changed one day after passage to eliminate trypsin.
    2. To change the medium, turn the aspiration apparatus on, attach the aspiration glass pipet, and aspirate all the medium.
    3. Add 20 mL of the growth medium (step 1.2).
  5. Passaging the cells
    1. Load the hood with the items needed in the course of the experiment.
    2. Use an aspiration glass pipet and aspirate away all media, ensuring the glass pipette is on the non-cell side of the flask. For this step, position the T75 flask vertically.
    3. Add ~10 mL of room temperature (RT) phosphate-buffered saline (PBS, Ca++ and Mg++ free) or Hanks' Balanced Salt Solution (HBSS, Ca++, and Mg++ free) on the non-cell side. Wash cells briefly with PBS by positioning the T75 flask horizontally with the cell side facing down.
    4. Immediately place the flask vertically and aspirate the PBS/HBSS. Repeat this washing and aspirating 3 times.
    5. Add 2 mL of trypsin (recombinant or animal-derived) on the cell side (T75 flask horizontal, cell side facing down). Incubate in a standard tissue culture incubator (37 Β°C, 5% CO2) for 4 min. Triturate it once after 2 min using a 5 mL pipette.
    6. After 4 min of total incubation, transfer the solution to a 15 mL conical tube. Add 8 mL of the growth solution to the conical tube (2 mL trypsinized cells + 8 mL of medium = 10 mL in total).
    7. Use another empty 15 mL conical tube with a filter and transfer the cells via a 25 mL pipette to achieve individual cells.
    8. Transfer 1/10 (1 mL) of the solution (cell + media + Tryp-LE) to a T75 flask with 20 mL of media. Alternatively, count the cells (step 1.7). Change the media the next day to have a non-trypsin media solution.
  6. Freezing the medium and the cells
    1. Thaw 100% FBS in a 4 Β°C refrigerator. Do not use a water bath or heat since this may damage the proteins in FBS.
    2. To prepare 50 mL of freezing media, mix 45 mL of DMEM, 5 mL of FBS, and 5 mL of DMSO. Aliquot it to 1-2 mL containers to prevent intermittent thawing and protein damage. Store them in -20 Β° or -80 Β°C freezer.
    3. For the remaining 9 mL of solution (step 1.5), add 1 mL of medium to reach 10 mL in total. Centrifuge at 300 x g for 4 min.
    4. Remove supernatant and resuspend in 1 mL of freezing medium (see above). Place the cells in a freezing container in -80 Β°C freezer. Move the cells to liquid N2 for long-term storage after 1 or 2 days.
  7. Counting the cells
    1. For the remaining 9 mL (step 1.5), add 1 mL of media to reach 10 mL in total. Centrifuge at 300 x g for 4 min.
    2. Remove the supernatant and resuspend in 4 mL of HBSS. Resuspend 10 Β΅L of cells in 80 Β΅L of HBSS + 10 Β΅L of 0.4% Trypan Blue, dilution factor = 10.
    3. Take 17 Β΅L of the solution and count four 4 x 4 squares in a hemocytometer. Average counts for the four 4 x 4 squares and multiply by 104x dilution factor to get cells/mL.

2. Surgery

NOTE: It is recommended to perform the surgery by two researchers, where one person is responsible for preparing the cells, mixing the dental cement, and generally assisting in the procedure, while the second person focuses on remaining sterile. Having a second manipulator to assist with the surgical procedure considerably reduces the likelihood of contamination occurring. Following best surgical practices would reduce the chances of post-operative complications. Figure 1A provides an overview of the components of the cranial window.

  1. General preparations
    1. Confirm that the procedure is approved by the local animal welfare institutional guidelines before starting.
      NOTE: This study used 5-month-old female NSG mice (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) (n = 5).
    2. Before surgery, autoclave all surgical instruments and ensure that all necessary supplies are available. Print the anesthesia and surgery records.
    3. Ensure that upon arrival, the animals have at least 1 week of acclimatization to the animal husbandry room to reduce additional post-operative distress.
    4. On the day of surgery, ensure that all devices (microscope, heating pad, sterilizer, drill, vacuum, etc.) are ready to use. Confirm that the anesthesia machine contains enough isoflurane and refill if necessary. For new users, the cranial window procedure can take up to 2 h per animal; therefore, having enough isoflurane is crucial.
    5. Place the glass windows and head bars in alcohol and prepare a container with saline. This will ensure a smooth workflow without any major breaches in sterility and keep the time under anesthesia for each animal as short as possible.
    6. Open all surgical materials on a sterile surface on the working station. For example, the inside of a sterile gauze packaging can be used for this purpose. Use the tips-only technique. When not using surgical instruments, place the tips on a sterile surface, such as the inside of the packaging of sterile gauze.
    7. When performing multiple surgeries, place all surgical instruments in the sterilizer in between surgeries to disinfect them. When performing surgeries on more than 5 animals, use a new set of autoclaved instruments. Switch out the drill tip when it becomes blunt for a new one to avoid tissue trauma.
  2. Anesthesia and preparations for surgery
    NOTE: The anesthesia setup is identical for the surgery, as well as for imaging.
    1. Anesthetize the mouse using isoflurane (3%-5% for induction) in an anesthetic chamber. After ensuring adequate anesthetic depth by testing the pedal withdrawal reflex (foot pad pinch on both hind feet), transfer the animal to a preparation working station. Maintain anesthesia over a nose cone (1%-2%). Here, apply an eye ointment to prevent corneal damage. Regularly control the loss of reflexes during surgery by checking the paw reflex.
    2. If any identification of the animal is required, use an ear punch tool or scissors to mark the ears or use a marker to mark the tail.
    3. Remove the fur covering the skull between the ears and eyes with a depilatory cream. Leave the cream as long as indicated (30-60 s) by the manufacturer to avoid skin irritation. Make sure that the cream comes in contact with the hair roots by applying it against the direction of hair growth. Avoid that the depilatory cream comes in contact with the eyes. Remove any cream and hair remnants by cleaning the area with saline. Alternatively, use clippers.
    4. To avoid any intra- and post-operative pain, infection, or swelling, administer non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anti-inflammatory agents, and antibiotics. Administer carprofen (5-20 mg/kg, subcutaneous [SQ]), buprenorphine - sustained release (1 mg/kg SQ), cefazolin (20 mg/kg SQ), and dexamethasone (0.2 mg/kg SQ) before surgery. Administer approximately 0.3 mL of 0.9% saline SQ to avoid dehydration.
    5. Following, scrub the area by alternately swabbing povidone-iodine and isopropyl alcohol three times in circular motions from the middle of the skull to the periphery.
  3. Craniotomy procedure
    1. Transfer the animal to the surgical table and place it in ventral recumbency on a heating pad (~37 Β°C) to ensure isothermal conditions during the procedure. Hypothermia in rodents significantly reduces survival rates and prolongs the post-operative recovery phase.
    2. Place the head in the stereotactic frame by positioning the ear bars and incisor bars. For the ear bars, find the zygomatic arch and insert the bars behind the arches. Start by securing the contralateral bar with the dominant hand (e.g., secure the left bar with your right hand if you are right-handed) and then secure the opposite side. Adjust the positions of the ear and incisor bars by turning the screws if required.
    3. Reapply eye ointment if necessary, and use a piece of aluminum foil to cover the eyes. This will prevent any damage caused by the bright microscope light and UV light used to cure the cyanoacrylate glue later (step 2.5).
    4. Before incision, check again for toe pinch reflex; if necessary, adjust anesthesia accordingly. Connect the animal to the anesthesia monitoring device by positioning the sensor on the hind paw. Measuring the heart rate and blood oxygen concentration would help reduce mortality and improve post-operative recovery. Additionally, acquire the respiratory rate by visually inspecting the chest movement.
    5. Cover the body of the animal with a drape to avoid hypothermia and contamination. Perform one final povidone-iodine swab before starting the surgery.
    6. Put on gloves and a clean lab coat.
      NOTE: Using sterile gloves is encouraged due to the invasiveness of the procedure and to lower the risk of any post-operative infection and inflammation resulting in morbidity and loss of image quality in 2P-IVM (section 5).
    7. Lift the skin on the skull and create an incision by holding the scissors between the right eye and ear and cutting towards the left side of the skull following the incision marks. Remove the resulting round skin flap.
      NOTE: Depending on the region of interest in the brain and the window size, the incision site and diameter can vary. The size of the incision needs to be bigger than the diameter of the head to accommodate room for mounting (step 2.5). If needed, the skin surrounding the incision can be gently dissected to create more space.
    8. Remove the periosteum by gently scratching the skull surface with a scalpel blade or a microcurrette. Exercise caution when removing the periosteum around the cranial sutures since those areas are fragile and more prone to bleeding. Use saline and a vacuum to keep the surgical area clean from debris. Scratch the periosteum to ensure better adherence to the cyanoacrylate glue and dental cement (step 2.5)
    9. Identify the region of the brain to perform the cell injection. For this, use an atlas of the stereotactic coordinates of the mouse brain. Per the brain coordinates, mark the position of the cranial window by using a biopsy punch in the same diameter as the window, a surgical pen, or an autoclaved pencil.
    10. Hold the drill in the dominant hand and any other instrument (syringe, forceps) in the non-dominant hand. Avoid prolonged drilling in the same spot. The drill should be used in bursts to avoid overheating. During these breaks, apply cold saline to the calvarium to keep the surgical view clean and to prevent overheating. Use the sensory feedback from the drill tip to detect when the skull has been perforated completely.
    11. Use cold saline, in combination with a vacuum, to clean the skull surface. Do not use gauze or a cotton tip applicator after opening the calvarium since remnants of cotton threads may lead to a foreign body reaction upon sealing the brain window.
    12. While drilling, ensure that the trajectory and diameter are the same size as those of the glass coverslip. Do this by positioning the glass coverslip on top of the skull and confirming that the glass coverslip will fit exactly inside the cranial window.
    13. Once it is possible to depress the skull flap by gently pressing on it, use forceps to carefully remove the fragment from the surgical field (Figure 1B, left). If it is not yet possible to depress the skull, continue drilling in the areas of the cranial window that are still connected to the rest of the skull and reevaluate.
    14. If minor bleeding occurs, use a hemostatic sponge combined with light pressure or alternatively, ice cold saline, to help reduce blood loss.
  4. Cell implantation
    1. Prepare and count the cells to be implanted as described in (step 1.7). Ensure that the cell number is 200,000 cells/Β΅L.
      NOTE: Suspending the cells in a membrane matrix that solidifies at RT is recommended. This will improve the success rate of implanted cells in the brain parenchyma.
    2. Transfer the cells in a container with ice to the surgical room. Use a gastight microliter syringe. Before aspiration, keep the syringe on ice to avoid temperature differences.
    3. After aspirating 1 Β΅L, position the syringe inside the stereotactic frame.
      NOTE: An automated stereotactic coordinate device showing the positions in the X, Y, and Z axes can be used to save time. It is also possible to manually calculate the positions based on lambda. Injecting more than 1.5 Β΅L is not recommended. This will ensure that the injected area does not overfill, causing unsuccessful implantation, growth outside the brain parenchyma, or metastases.
    4. Perform implantation in the V2MM region (visual cortex 2, mediomedial part) of the brain, which corresponds to approximately medial to lateral (M-L): -1.2 to -1.6 mm, and dorsal to ventral (D-V): -2.6 to -3.5 mm coordinates.
      1. For two-photon imaging (step 4.6), implant the cells in the superficial brain areas so that the tumor mass can be visualized through the cranial window later on. Inject 0.5 Β΅L (100,000 cells) at anterior to posterior (A-P): 0.8 mm depth. Move the needle slowly, in a stepwise manner, when entering the brain and wait for 30 s after injection (Figure 1B, middle column).
      2. Use the same approach when retracting the needle and exiting the brain tissue. Avoid injecting close to the ventricles since the cerebrospinal fluid might encourage metastasis in the central and peripheral nervous systems.
  5. Closure of the cranial window
    1. Move the head bar and glass coverslip from alcohol to a saline solution. Use a vacuum tip or forceps to navigate those components to the surgical site.
    2. Position the glass coverslip inside the cranial window and place a small amount of cyanoacrylate glue between the skull and the glass coverslip. UV-activated cyanoacrylate glue reduces the curing time and avoids accidental displacement. If any glue spills on the glass coverslip, remove it with a cotton tip applicator or by gently scratching it off with the blunt side of a scalpel before it cures completely.
      CAUTION: UV light is harmful to the eyes and skin. Avoid eye and skin contact while curing the glue.
    3. After securing the glass coverslip in the cranial window, apply the head bar. Mix the two-component dental cement, position the head bar, and apply the cement to the surrounding area, ensuring contact between the skull and the head bar. Carefully clean any superfluous cement with the tip of a syringe, a scalpel, or a drill tip.
      NOTE: Dental cement solidifies very quickly, so it is advised to apply it in a timely manner.
    4. After sealing the cranial window, identify if any skull areas between the dental cement and skin are still exposed. If that is the case, apply surgical glue to cover up the skull by closing the skin. Alternatively, perform a single suture with an absorbable suture material.

3. Post-surgical recovery and tumor growth

  1. Recovery
    1. Monitor the animal on a heated pad in a recovery cage until it regains full consciousness. House the animals separately post-surgery to reduce the risk of injury.
    2. Administer a recovery diet, such as commercially available water gels with electrolytes or sugars. Alternatively, supply moistened standard lab chow to ensure easy nutrition and avoid dehydration and hypoglycemia.
  2. Monitoring
    1. Upon recovery, monitor the animal daily for signs of pain, distress, or infection. If needed, administer analgesics, anti-inflammatory drugs, or antibiotics. If an animal reaches the study endpoint, euthanize it humanely. Following the final imaging session, euthanize the mouse by carbon dioxide asphyxiation, followed by cervical dislocation.
      NOTE: Examples of early euthanasia criteria include but are not limited to significant weight loss (>20%), neurological disorders, dyspnea, excessive bleeding during surgery, or pronounced stereotypical behavior. Inspect the cranial window and clean it with saline or alcohol when necessary.
    2. To track tumor growth and plan the imaging time points, perform whole-body bioluminescence imaging (BLI). For this, inject 150 mg/kg D-luciferin intraperitoneally and image the animal after 5-15 min.

4. Nanoparticle synthesis

  1. Particle preparation
    1. Add 11.17 mL of Ferumoxytol (6 mmol Fe in total) to a solution containing 50 mL of 5 M NaOH, 20 mL of deionized water (DI water) and 20 mL of epichlorohydrin. Observe phase segregation at this stage. Incubate the mixture at RT under gentle shaking for 24 h.
    2. After 24 h, the solution becomes uniform. Remove excess epichlorohydrin using dialysis tubing (12,000-14,000 Da cutoff) against water for 3 days.
    3. After dialysis, transfer the solution remaining in the tube into a glass bottle (total volume ~110 mL). Add 30 mL of ammonia hydroxide, and stir the mixture at 37 Β°C for 18-20 h.
    4. After stirring, repeat dialysis against water for 3 days. Transfer the solution remaining in the dialysis tubing into a new glass bottle with a total volume ~110 mL.
  2. Fluorescein isothiocyanate (FITC) conjugation
    1. Take out 27.5 mL of amine-functionalized particles for FITC conjugation. Concentrate the particles using a 10 kDa ultracentrifugation filter and wash with a pH 9 (Na2CO3/NaHCO3) buffer at 5752 x g at 25 Β°C for 10 min.
    2. Add 4 mL of the solution into the filter and ultracentrifuge the tube at 5752 x g at 25 Β°C for 10 min. Discard the filtrate and refill the filter with buffer for a second round of washing with the same protocol.
    3. Discard the filtrate and collect the solution in the filter using a pipet. Estimate the molar concentration of the particle by the mass concentration of Ferumoxytol, assuming the diameter of each particle is 5 nm.
    4. Dissolve FITC in anhydrous dimethyl sulfoxide (DMSO) at 10 mg/mL. Slowly add 1.4 mL of DMSO-dissolved FITC into the concentrated amine-functionalized particle. The molar ratio of FITC: particle is 20:1. After that, incubate the solution at 4 Β°C for 8 h in the dark.
    5. Quench the reaction by adding excess NH3.H2O (the final concentration of NH3.H2O is 50 mM), then letting the solution stay at 4 Β°C in the dark for 2 h. Wash away excess FITC using Na2CO3/NaHCO3 (pH 9) buffer through a 10 kDa filter at 5752 x g at 25 Β°C for 10 min. The final pH of the solution is adjusted to 7.4 using HCl aqueous solution.

5. 2P-IVM

NOTE: For the 2P-IVM sessions, a Prairie Ultima IV microscope with a custom stage (Figure 2 and Supplemental Coding File 1) that allows adjusting the position of the cranial window horizontally and vertically was used. Fiji software was used for post-processing and image analysis. This way, the laser beam can be adjusted to hit the glass at a 90 Β° angle, reducing artifacts and improving imaging quality.

  1. Imaging session
    1. Turn on the Ti-Sapphire laser. Turn on the main system switch and Prairie View software.
    2. Anesthetize the animal, as described above (step 2.2). Perform imaging sessions for up to 2 h per animal. Keep the imaging time to a minimum to reduce the risk of anesthesia complications and associated morbidity or mortality.
    3. Immobilize the mouse under the two-photon microscope using a custom stage (Figure 1B, right column). Place the animal in a prone position on a heated pad designed for rodent surgery and secure it lightly using tape while paying attention to not constrict the thorax. Place a drop of water on the cranial window and adjust the focus.
    4. Acquire heart rate and blood oxygenation to monitor the animals' vital parameters. Position the sensor on the hind paw and keep the monitoring device outside the two-photon imaging chamber.
    5. Once the animal is on the microscope stage, adjust the head position. Using the binoculars and widefield fluorescent illumination, set the red fluorescent protein (RFP) filter and find the desired imaging field of view (Figure 1B, right column).
    6. Once sample orientation and field of view are determined, switch the microscope from widefield mode to light scanning microscopy mode (LSM).
    7. Make sure the Ti-Sapphire laser is mode-locked at 920 nm, and all shutters are open. Bring the GaAsP photomultiplier tube detectors (PMT) voltages up to 500-600 V. Use two PMTs with filter sets with band passes at 595/50 (RFP) and 525/50.
    8. Press Live Image and slowly modify the pockel cell to increase the laser power at the sample until an image is visible.
    9. Once a clear image is achieved, use the software and the motorized stage to set the top and bottom of an image stack within the desired sample area. Beware of the step size and take into consideration that the Z-axis adjusts the depth of the lens.
    10. With increasing depth, the images will get darker. Increase the pockels/PMT gain slowly to keep the image bright. Be careful not to use too much power as it can lead to phototoxicity and tissue damage.
    11. Set a save path and start the Z series. It will automatically traverse to the starting and ending positions using the set pockel/PMT settings. Once the stack is complete, use the playback to look over the stack for quality. Once acquiring the necessary images is complete, turn off the Ti-Sapphire laser.
    12. Move the animal to a recovery cage, as described above (step 3.1).
    13. Exit Prairie view and ensure all the data is saved/transferred. Shut down the computer and shut down all hardware.
  2. Post-processing with FIJI
    NOTE: Fiji is an open-source software focused on biological image analysis21.
    1. Download FIJI with respect to the operating system. Unzip the folder contents and run the .exe file.
    2. Drag the .env file gathered from the two-photon imaging to the dialogue box. Split the channels into different image boxes. This will create two different images with different channels, one containing the cell signal and the other the particle signal.
    3. Copy one of the images and click on File > New > Internal Clipboard to create another image. Rename one of the images as Source and the other as Copy.
    4. Use the copy image and click on Process > Enhance contrast in the dialogue box. Click Normalize and OK and then Process > Smooth. This image is used to create a mask and not for analysis. Click on Image > Adjust > Threshold in the dialogue box. Use the sliding scale and method that is appropriate to extract, then click Apply.
    5. Use Process > Binary > Erode to erode single pixels in the background and click Process > Binary > Dilate to add back pixels to the image.
    6. Click on Process > Image Calculator in the dialogue box, select the source image as the first and select the second image as Copy. Use AND to create the intersection of both images. Repeat the same step for the other channel image.
    7. For signal analysis outside of the vascular region, open an unaltered copied image and delete the vascular area of the signal with the Freehand ROI tool.
    8. Set desired parameters by going to Analyze > Set Measurements. Make sure Area, Integrated Density, and Mean Grey Value are checked.
    9. Now analyze by Analyze > Measure. A window with the measurements will pop up. Copy the data into a spreadsheet.
    10. Now select a small area of the image that has no fluorescence. This will be the background.
    11. Click Analyze > Measure for that region. Copy data into a spreadsheet.
    12. Save the resulting image as File > Save as > Analyze file type for remeasurements or publication purposes.

Results

Here, we performed cranial window surgery and engrafted C6 cells in an NSG mouse model of GBM (n = 5). A proper seal between all components involved in the creation of the window (Figure 1A) will ensure the windows' durability for long-term imaging and, additionally, reduce morbidity. Using the stage adapted for in vivo 2P-IVM (Figure 2), we could image animals under anesthesia for up to 2 h without any major motion artifacts. Approximately 10 min a...

Discussion

We present a method for real-time in vivo NP tracking using 2P-IVM through a cranial window to evaluate the tumor delivery of fluorescent-labeled iron oxide NPs. The surgical technique for this procedure requires a steady hand and advanced experimental surgical skills. It is advisable to practice using carcasses or phantoms before moving forward to live animal experience. As an alternative, Hoeferlin et al. implemented a robotic drill to reduce thermal damage, minimize surgical technique variability, and standar...

Disclosures

The authors declare that they have no conflict of interest.

Acknowledgements

We would like to thank the Stanford Wu Tsai Neuroscience Microscopy Service, the Stanford Center for Innovations in In Vivo Imaging (SCi3) - small animal imaging center, NIH S10 Shared Instrumentation Grant (S10RR026917-01, PI Michael Moseley, Ph.D.), and Stanford Preclinical Imaging Facility at Porter Drive for providing the equipment and infrastructure for this project. This work was supported by a grant from the National Institute for Child Health and Human Development, grant number R01HD103638. We would like to thank the Schnitzer Group, Stanford University; the Zuo lab, University of Santa Cruz; and the Neurovascular Imaging Laboratory, Boston Photonic Center, University of Boston, for educational discussions on two-photon imaging and cranial window models.

Materials

NameCompanyCatalog NumberComments
0.9% sodium chloride infusion solutionBaxter Corp533-JB1301P

Dulbecco's Modified Eagle Medium
Invitrogen11965-092
1 mL syringesBDLuer-Lok syringe, REF309628
10%Β FBSThermo fisherCytiva SH30910.03HI
10% DMSOSigma-AldrichD8418-50ML
2-photon microscopePrairie Technologies, BrukerPrairie Ultima IV
Alcohol applicators, 70%Medline Industries, LPMDS093810
Alcohol, spray bottleDecon Labs IncDecon SaniHol, 04-355-122
Aluminum foilReynold BrandsReynold Wrap non-stick aluminum foil
Anesthesia machinePatterson ScientificSAS3
Anesthesia monitoringΒ Kent ScientificΒ MouseSTAT Jr. Rodent Pulsoxymeter
Antibiotic-Antimycotic (100x), liquidInvitrogen15240-096
Betadine applicatorsProfessional Disposables International, IncS41125
Biopsy punch, 5 mmΒ MiltexSize 5
Buprenorphine sustained releaseZoo PharmBup SR Lab, 1.0 mg/mLA generic drug can be used instead.Β 
C6 rat glioma cell lineATCC (American Tissue Culture Collection)CCL-107
CannulasBD16 G, 1.1/2”, 30 G, 1”
CarprofenPfizerΒ Rimadyl, 50 mg/mlA generic drug can be used instead.Β 
CefazolineSagent Pharmaceuticals25021-101-10, 1 g/vialA generic drug can be used instead.Β 
Cell strainer, 40 Β΅mFisher Scientific87711
Cotton tip applicators, 6” Dyad Medical Sourcing, LLCHCS1005
Dental cementStoelting Co51459Dental cement kit, clear, 2 components
DexamethasoneBimeda138RX, 2 mg/mLA generic drug can be used instead.Β 
DietGelClearH2ORecovery, 72-06-502
DrapeΒ Cardinal HealthBio Shield Wrap
DrillSaeyang MicrotechEscort Pro, B08350
Drill tipsΒ Hager & Meissinger GmbHREF310104001001005Size 005, US 1/4
FIJI imaging analysis softwareNational Institute of Healthhttps://imagej.net/software/fiji/
ForcepsFisher Scientific13-812-41
GauzeFisher HealthCareSterile Cotton Gauze Pad, 4 x 4”, 22-415-469
GelfoamΒ Ethicon Inc.Β Surgifoam absorbable gelatin sponge, Ref. 1972
GerminatorΒ Cellpoint ScientificΒ Germinator 500, No. 11688
Glass coverslips, 5 mm diameterFisher ScientificMenzel Cover glassΒ 
Gloves, non-sterileFisher ScientificNitrile powder-free medical examination gloves
Gloves, sterileMedline Industries, LPMDS104070
Hair removal creamChurch & DwightNair Hair remover lotionΒ 
Hamilton syringeHamilton Company IncGastight #1701, 10 Β΅L
HBSS without Ca, MgFisher ScientificPI88284
Head barHongway5 mm inner diameter O-rings
Heating padStoelting Co.Β Rodent warmer X2
Insulin syringesExel International Medical ProductsΒ 29G x 1/2β€³
Iron oxide nanoparticlesCovis Pharma GmbHFeraheme ferumoxytol injection, 510 mg/17 mL, 59338077501
IsofluraneDechra26675-46-7
MiceJackson LaboratoriesNSG, Strain 005557
Microscope (surgery)Seiler MedicalSeiler IQ Q-100-220
NanoparticlesCustomIron oxide nanoparticles (Ferumoxytol) labeled with fluorescein isothiocyanate
Ophtalmic ointmentMajor pharmaceuticalsLubrifresh P.M. nighttime ointment, 203964
OxygenLinde Gas & Equipment Inc.Β High Pressure Steel K Style Cylinder, 249CF, 2000PSIG, CGA 540
Plastic cupsGeorgia-Pacirif Consumer ProductsDixie Portion Cup, 2 oz., Plastic, Clear, PK2400
Polyethylene tubingBraintree Scientific50-195-5494
ScaleOhaus CorpCR2200
ScalpelIntegra Life Sciences Production CorpIntegra Miltex Stainless steel disposable scalpel
ScissorsFisher Scientific13-804-18
SealantHenkel CorpLoctite 4014
Single use lab gownHigh Tech Conversions17-444-081
Stereotactic frameStoelting Co.Β Stoelting New Standard TM
Sterile Vacuum Bottle Top Filtration SystemsFisher ScientificS2GPU05RE, MilliporeSigma NO.:S2GPU05RE
Styrofoam boxN/AN/A
Surgical glovesCardinal Health19-163-108
Surgical glue, 3M Vetbond tissues adhesive3M Animal Care Prodcuts1469SB
Tail vein cathetherCustomConsists of two 30 G cannulas connected with sillicone tubingΒ 
TrypLE Express (1x), no phenol redInvitrogen12604-039
Ultraviolett torchSpring sunshine technologyConsciot

References

  1. Denk, W., Strickler, J. H., Webb, W. W. Two-photon laser scanning fluorescence microscopy. Science. 248 (4951), 73-76 (1990).
  2. Wang, Z., McCracken, S., Williams, P. R. Transpupillary two-photon in vivo imaging of the mouse retina. J Vis Exp. 168, 61970 (2021).
  3. Zhang, K., et al. In vivo two-photon microscopy reveals the contribution of Sox9+ to kidney regeneration in a mouse model with extracellular vesicle treatment. J Biol Chem. 295 (34), 12203 (2020).
  4. Jang, W. H., et al. Two-photon microscopy of Paneth cells in the small intestine of live mice. Sci Rep. 8 (1), 14174 (2018).
  5. Ihler, F., Bertlich, M., Weiss, B., Dietzel, S., Canis, M. Two-photon microscopy allows imaging and characterization of cochlear microvasculature in vivo. Biomed Res Int. 2015, 154272 (2015).
  6. Matsuura, R., et al. Intravital imaging with two-photon microscopy reveals cellular dynamics in the ischeamia-reperfused rat heart. Sci Rep. 8 (1), 15991 (2018).
  7. Veres, T. Z., et al. Intubation-free in vivo imaging of the tracheal mucosa using two-photon microscopy. Sci Rep. 7 (1), 694 (2017).
  8. Zong, W., et al. Large-scale two-photon calcium imaging in freely moving mice. Cell. 185 (7), 1240-1256.e30 (2022).
  9. Takasaki, K., Abbasi-Asl, R., Waters, J. Superficial bound of the depth limit of two-photon imaging in mouse brain. eNeuro. 17 (1), (2019).
  10. Birkner, A., Konnerth, A. Deep two-photon imaging in vivo with a red-shifted calcium indicator. Methods Mol Biol. 1929, 15-26 (1929).
  11. Busche, M. A. In vivo two-photon calcium imaging of hippocampal neurons in Alzheimer mouse models. Methods Mol Biol. 1750, 341-351 (2018).
  12. Li, L., et al. A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson's disease models. Nat Commun. 5, 3276 (2014).
  13. Madden, K. S., Zettel, M. L., Majewska, A. K., Brown, E. B. Brain tumor imaging: live imaging of glioma by two-photon microscopy. Cold Spring Harb Protoc. 2013 (3), (2013).
  14. Ricard, C., et al. Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice. Sci Rep. 6, 26381 (2016).
  15. SoubΓ©ran, A., et al. Effects of VEGF blockade on the dynamics of the inflammatory landscape in glioblastoma-bearing mice. J Neuroinflammation. 16 (1), 191 (2019).
  16. Zhang, W., et al. Real-time vivo reveals specific nanoparticle target binding in a syngeneic glioma mouse model. Nanoscale. 14 (15), 5678-5688 (2022).
  17. Wartchow, K. M., et al. Treatment with cyclic AMP activators reduces glioblastoma growth and invasion as assessed by two-photon microscopy. Cells. 10 (3), 556 (2021).
  18. Jiang, L. W., et al. Label-free detection of fibrillar collagen deposition associated with vascular elements in glioblastoma multiforme by using multiphoton microscopy. J Microsc. 265 (2), 207-213 (2017).
  19. Chen, Z., Ross, J. L., Hambardzumyan, D. Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages. Proc Natl Acad Sci U S A. 116 (28), 14254-14259 (2019).
  20. Zhang, Y. S., et al. Labeling human mesenchymal stem cells with gold nanocages for in vitro and in vivo tracking by two-photon microscopy and photoacoustic microscopy. Theranostics. 3 (8), 532-543 (2013).
  21. Schindelin, J., et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 9 (7), 676-682 (2012).
  22. Hoeferlin, G. F., Menendez, D. M., Krebs, O. K., Capadona, J. R., Shoffstall, A. J. Assessment of thermal damage from robot-drilled craniotomy for cranial window surgery in mice. J Vis Exp. 189, 64188 (2022).
  23. Holtmaat, A., et al. high-resolution imaging in the mouse neocortex through a chronic cranial window. Nat Protoc. 4 (8), 1128-1144 (2009).
  24. Heo, C., et al. A soft, transparent, freely accessible cranial window for chronic imaging and electrophysiology. Sci Rep. 6, 27818 (2016).
  25. Kim, T. H., et al. Long-term optical access to an estimated one million neurons in the live mouse cortex. Cell Rep. 17 (12), 3385-3394 (2016).
  26. KΔ±lΔ±Γ§, K., et al. Chronic cranial windows for long term multimodal neurovascular imaging in mice. Front Physiol. 11, 612678 (2021).
  27. Helm, P. J., Ottersen, O. P., Nase, G. Analysis of optical properties of the mouse cranium-implications for in vivo multi photon laser scanning microscopy. J Neurosci Methods. 178 (2), 316-322 (2009).
  28. Lu, W., Sun, Q., Wan, J., She, Z., Jiang, X. G. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res. 66 (24), 11878-11887 (2006).
  29. Zhang, B., et al. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Biomaterials. 34 (36), 9171-9182 (2013).
  30. Xin, H., et al. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(Ι›-caprolactone) nanoparticles: In vitro and in vivo evaluation. Int J Pharm. 402 (1-2), 238-247 (2010).
  31. Valable, S., et al. In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma. Neuroimage. 40 (2), 972 (2008).
  32. Jia, Y., et al. Phototheranostics: Active targeting of orthotopic glioma using biomimetic proteolipid nanoparticles. ACS Nano. 13 (1), 386-398 (2021).
  33. Asan, L., et al. Cellular correlates of gray matter volume changes in magnetic resonance morphometry identified by two-photon microscopy. Sci Rep. 11, 4234 (2021).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Two photon Intravital MicroscopyGlioblastomaBrain CancerNanoparticlesDrug DeliveryBlood brain BarrierPreclinical ImagingMultimodal ImagingMRIMPIPositron Emission TomographyPhotoacoustic Ultrasound

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright Β© 2025 MyJoVE Corporation. All rights reserved